Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
 
 
Email
gmstek@nus.edu.sg
 

Refined By:
Funding Agency:  National Medical Research Council

Results 1-20 of 20 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
12003Alpha synuclein promoter and risk of Parkinson's disease: Microsatellite and allelic size variabilityTan E.-K. ; Tan C.; Shen H.; Chai A.; Lum S.-Y.; Teoh M.-L.; Yih Y.; Wong M.-C.; Zhao Y.
22018Association of LRRK2 haplotype with age at onset in Parkinson diseaseXiao B.; Deng X.; Ng E.Y.-L.; Allen J.C. ; Jr.; Lim S.-Y.; Ahmad-Annuar A.; Tan E.-K. 
32017B vitamins and cognition in subjects with small vessel disease: A Substudy of VITATOPS, a randomized, placebo-controlled trialTing S.K.S. ; Earnest A. ; Li H. ; Hameed S. ; Chang H.M. ; Chen C.L.H. ; Tan E.-K. 
42016Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese health studyTan L.C.; Methawasin K.; Tan E.-K. ; Tan J.H.; Au W.-L. ; Yuan J.-M.; Koh W.-P.
52003Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: A study in ethnic ChineseTan E.-K. ; Tan C.; Fook-Chong S.M.C. ; Lum S.Y.; Chai A.; Chung H.; Shen H.; Zhao Y.; Teoh M.L.; Yih Y.; Pavanni R. ; Chandran V.R.; Wong M.C. 
62006Exploring the relationship between caffeine intake and essential tremorPrakash K.M. ; Fook-Choong S.; Yuen Y.; Tan E.K. 
72004Genetic analysis of DJ-1 in a cohort Parkinson's disease patients of different ethnicityTan E.-K. ; Tan C.; Zhao Y.; Yew K.; Shen H.; Chandran V.R.; Teoh M.-L.; Yih Y.; Pavanni R. ; Wong M.-C. 
82003Genetic analysis of Nurr1 haplotypes in Parkinson's diseaseTan E.-K. ; Chung H.; Zhao Y.; Shen H.; Chandran V.R.; Tan C.; Teoh M.-L.; Yih Y.; Pavanni R. ; Wong M.-C. 
92017GWAS-linked PPARGC1A variant in Asian patients with essential tremorXiao B.; Deng X.; Ng E.Y.-L.; Tio M.; Prakash K.M. ; Au W.L. ; Tan L. ; Zhao Y.; Tan E.-K. 
102005Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: Clinical associationTan E.K. ; Puong K.Y.; Chan D.K.Y.; Yew K.; Fook-Chong S. ; Shen H.; Ng P.W.; Woo J.; Yuen Y. ; Pavanni R. ; Wong M.C. ; Puvan K. ; Zhao Y.
112015Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese populationYu W.-J.; Cheng L.; Li N.-N.; Wang L.; Tan E.-K. ; Peng R.
122017Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative DiseasesZhou Z.-D. ; Saw W.-T.; Tan E.-K. 
132017p62-Mediated mitochondrial clustering attenuates apoptosis induced by mitochondrial depolarizationXiao B.; Deng X.; Lim G.G.Y.; Zhou W.; Saw W.-T.; Zhou Z.D.; Lim K.-L. ; Tan E.-K. 
142017Screening for TMEM230 mutations in young-onset Parkinson's diseaseMa D. ; Foo J.N.; Yulin Ng E.; Zhao Y.; Liu J.-J. ; Tan E.K. 
152017Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondriaXiao B.; Deng X.; Lim G.G.; Xie S. ; Zhou Z.D.; Lim K.-L. ; Tan E.-K. 
162016Susceptibility-weighted MRI of extrapyramidal brain structures in Parkinsonian disordersSchneider E. ; Ng K.-M.; Yeoh C.-S.; Rumpel H. ; Fook-Chong S. ; Li H.-H. ; Tan E.-K. ; Chan L.-L. 
172017Targeting LRRK2 in Parkinson's disease: an update on recent developmentsChan S.L.; Tan E.-K. 
182005The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patientsTan E.K. ; Shen H.; Tan L.C.S. ; Farrer M.; Yew K.; Chua E.; Jamora R.D.; Puvan K. ; Puong K.Y.; Zhao Y.; Pavanni R. ; Wong M.C. ; Yih Y.; Skipper L.; Liu J.-J. 
192007The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: Genetic and functional evidenceTan E.K. ; Zhao Y.; Skipper L.; Tan M.G.; Di Fonzo A.; Sun L.; Fook-Chong S.; Tang S.; Chua E.; Yuen Y.; Tan L.; Pavanni R.; Wong M.C.; Kolatkar P.; Lu C.S.; Bonifati V.; Liu J.J.
202018Towards better cellular replacement therapies in Parkinson diseaseSun A.X. ; Tan E.-K.